Loading...
Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report
INTRODUCTION: The clinical efficacy of osimertinib for patients with lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations is unclear. Few case reports exist on the successful treatment of such tumors with osimertinib. We report a case wherein osimertinib...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572000/ https://ncbi.nlm.nih.gov/pubmed/33080698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000022628 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|